Hyderabad: Hyderabad-based vaccine company Biological E Limited (BE) on Saturday announced that its Corbevax Covid-19 vaccine has been approved by the Drug Controller General of India (DCGI) as a heterologous booster dose to individuals aged 18 years and above. This can be used after six months of administration of primary vaccination (two doses) of Covaxin […]
Hyderabad: Hyderabad-based Optimus Pharma launched their frontline Covid-19 medication molnupiravir in the Indian market, as they have received permission for the restricted emergency use for Covid-19 drug. Optimus Pharma is ready with a commercial quantity of the drug. The company has completed its phase 3 clinical trials on 1,218 subjects across 29 geographical study sites […]
Hyderabad: Hyderabad-based Hetero Group said that the Drug Controller General of India (DCGI) has issued Emergency Use Authorization (EUA) for the generic version of Tocilizumab in India for the treatment of Covid-19 in hospitalised adults. It is aimed to treat individuals who are receiving systemic corticosteroids and require supplemental oxygen, non- invasive or invasive mechanical […]
The Companies manufacturing COVID-19 vaccination in India have given only "Emergency Use Authorization for vaccinating people of 18 years age and above
This is a major relief for India which has the second highest number of infections in the world, after the US. The Central government plans to vaccinate nearly 30 crore people in the first phase of drive in the next six to eight months.
